Company intelligence / Profile preview

BioGrowing

Shanghai, Shanghai Municipality, China

Ownership: Private
Development stage: Other

Overview

BioGrowing has over two decades of experience and operates one of Asia’s largest probiotics production bases. The company exports to more than seventy countries and has been recognized as a top supplier for immunity and digestion probiotics. Its R&D team focuses on both traditional and next-generation probiotic applications including postbiotics and heat-resistant strains. No clinical trial results typical of pharmaceutical development are reported; products are commercialized as ingredients or supplements rather than drugs.

Therapeutic areas: Metabolic DisordersGastroenterologyImmunologyOther
Modalities: Live biotherapeutic product therapy (probiotics)Microbial therapy (probiotics)Functional food ingredient (postbiotics, heat-resistant probiotics)
Industry: Food & Nutrition

Beyond the preview

Go deeper on BioGrowing.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioGrowing.

Explore the full profile